Articles Vol. 67 No. 10 04/11/2026

CURRENT STATUS OF PSYCHOACTIVE SUBSTANCE USE (DAST-10) AMONG PATIENTS AGED 15-24 YEARS AT THE NATIONAL INSTITUTE OF MENTAL HEALTH, BACH MAI HOSPITAL

Le Thi Phuong Thao, Le Thi Thu Ha, Vu Van Hoai, Nguyen Thi Thuy Nga, Luong Thi Thuy, Cao Thi Thanh Tam
DOI: 10.52163/yhc.v67i10.6968
11 Views
0 Downloads
Abstract

Objective: To describe the current status of psychoactive substance use, as assessed by the DAST-10, among patients aged 15-24 years at the National Institute of Mental Health, Bach Mai Hospital.

Subjects and methods: A descriptive cross-sectional study was conducted among 153 inpatients aged 15-24 years receiving treatment at the National Institute of Mental Health, Bach Mai Hospital.

Results: Among the 153 adolescent inpatients, the prevalence of psychoactive substance use was 20.3%. The mean age at substance use initiation was 16.10 ± 2.51 years. According to the DAST-10, 77.4% of substance users were classified as having moderate to very high risk, of whom 45.1% required intensive assessment and intervention. Cannabis and electronic cigarettes (e-cigarettes) were the two most commonly used substances, reported by 45.2% and 41.9% of substance users, respectively.

Conclusion: Psychoactive substance use was relatively common among adolescent psychiatric inpatients and tended to begin at an early age. Most substance users were identified by the DAST-10 as being at a risk level requiring further assessment and intervention. Cannabis and electronic cigarettes (e-cigarettes) were the most commonly used substances, highlighting the need to strengthen screening and early intervention for substance use disorders among adolescents.

References
[1]
[1] United Nations Office on Drugs and Crime. World drug report 2025. Vienna, 2025 [cited 2026 Jul 9]. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html Google Scholar
[2]
[2] Volkow N.D, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry, 2023, 22 (2): 203-229. doi: 10.1002/wps.21073. Google Scholar
[3]
[3] Skinner H.A. The drug abuse screening test. Addict Behav, 1982, 7 (4): 363-371. doi: 10.1016/0306-4603(82)90005-3 Google Scholar
[4]
[4] The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva, 1992, 377 p. Google Scholar
[5]
[5] Report of the tenth meeting of the WHO Strategic and Technical Advisory Group of experts for maternal, newborn, child and adolescent health and nutrition, 12-14 November 2024. World Health Organization, Geneva, 2025, 71 p. Google Scholar
[6]
[6] Volkow N.D. Drugs, brains, and behavior: the science of addiction. How science has revolutionized the understanding of drug addiction? National Institute on Drug Abuse, 2020 [cited 2026 Jul 9]. https://nida.nih.gov/research-topics/addiction-science/drugs-brain-behavior-science-of-addiction Google Scholar
[7]
[7] Gobbi G, Atkin T et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiatry, 2019, 76 (4): 426-434. doi: 10.1001/jamapsychiatry.2018.4500 Google Scholar